1. Home
  2. BTMD vs PDSB Comparison

BTMD vs PDSB Comparison

Compare BTMD & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$2.20

Market Cap

71.0M

Sector

Health Care

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.83

Market Cap

62.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTMD
PDSB
Founded
2012
2005
Country
United States
United States
Employees
N/A
10
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.0M
62.0M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
BTMD
PDSB
Price
$2.20
$0.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$2.83
$9.00
AVG Volume (30 Days)
404.5K
653.9K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
722.22
28.16
EPS
0.06
N/A
Revenue
$192,219,000.00
N/A
Revenue This Year
$2.03
N/A
Revenue Next Year
$6.58
N/A
P/E Ratio
$33.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$0.51
52 Week High
$4.75
$1.55

Technical Indicators

Market Signals
Indicator
BTMD
PDSB
Relative Strength Index (RSI) 53.69 37.58
Support Level $1.97 $0.73
Resistance Level $2.44 $1.16
Average True Range (ATR) 0.19 0.08
MACD -0.02 -0.01
Stochastic Oscillator 64.37 4.25

Price Performance

Historical Comparison
BTMD
PDSB

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

Share on Social Networks: